Determination of Longus Colli Muscle Thickness by Ultrasonography

Sponsor
Istanbul University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05108103
Collaborator
(none)
200
1
15
13.3

Study Details

Study Description

Brief Summary

This study aims to assess the longus colli muscle thickness by ultrasonography in order to guide stellate ganglion blocks

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Stellate ganglion block is an interventional pain management procedure that is often performed for diagnostic and therapeutic purposes. It has long been performed with the guidance of fluoroscopy, and despite the increasing use of ultrasonography in recent years, fluoroscopy is still the gold standard method.

    In traditional fluoroscopic method, the needle is directed to the transverse process of the C6 vertebra, after touching the anterior tubercle (Chassaignac's tubercule) the needle is slightly withdrawn and following a negative aspiration, injection is performed.

    The ideal placement of the needle should be anterolateral to the longus colli muscle and deep to the prevertebral fascia. Further placement may cause intramuscular spread and superficial placement may cause injection in the carotid sheath or vascular structures. These are the most important reasons for clinical ineffectiveness. How far should the needle be withdrawn? Data is inconsistent in the literature.

    The primary aim of this study is to determine the distance from transverse process to longus colli muscles anterior border and from transverse process to carotid sheath's posterior border. Secondary aim is to investigate the relationship between longus colli muscle thickness and age, gender, height, weight, BMI and neck circumference.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    How Far Should The Needle Be Withdrawn for Stellate Ganglion Block: Determination of Longus Colli Muscle Thickness by Ultrasonography
    Actual Study Start Date :
    Mar 1, 2021
    Anticipated Primary Completion Date :
    Mar 1, 2022
    Anticipated Study Completion Date :
    Jun 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Distance between corpus and longus colli muscle's anterior border on C6 level (millimeters) [0 minutes]

      Distance between corpus and longus colli muscle's anterior border on C6 level will be evaluated with ultrasonography.

    Secondary Outcome Measures

    1. Distance between corpus and longus colli muscle's anterior border on C7 level (millimeters) [0 minutes]

      Distance between corpus and longus colli muscle's anterior border on C7 level will be evaluated with ultrasonography.

    2. Maximum anteroposterior width of longus colli muscle on C6 level (millimeters) [0 minutes]

      Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.

    3. Maximum anteroposterior width of longus colli muscle on C7 level (millimeters) [0 minutes]

      Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.

    4. Distance between esophagus and estimated needle plane (millimeters) [0 minutes]

      Distance between esophagus and estimated needle plane will be evaluated with ultrasonography.

    5. Neck circumference (centimeters) [0 minutes]

      Neck circumference

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age between 18 - 65 years,

    • Giving informed consent for examination, ultrasonographic evaluation and study participation

    Exclusion Criteria:
    • Having a chronic neck pain for more than 6 months,

    • Having any neurological or musculoskeletal conditions that may affect the anatomy of cervical region (cervical disc herniation, torticollis, severe scoliosis, vertebral malformation, spinal stenosis, myopathies, etc.)

    • Having a history of surgery or radiation therapy in the cervical region

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Halil Çetingök Istanbul Turkey 34093

    Sponsors and Collaborators

    • Istanbul University

    Investigators

    • Principal Investigator: Halil Çetingök, Ass. Prof., Istanbul University Istanbul Faculty of Medicine, Department of Pain Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Halil Cetingok, Assistant Professor, Istanbul University
    ClinicalTrials.gov Identifier:
    NCT05108103
    Other Study ID Numbers:
    • 2021/182
    First Posted:
    Nov 4, 2021
    Last Update Posted:
    Nov 15, 2021
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Halil Cetingok, Assistant Professor, Istanbul University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 15, 2021